Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer

Malla, S B, Byrne, R M, Lafarge, M W, Corry, S M, Fisher, N C, Tsantoulis, P K, Mills, M L, Ridgway, R A, Lannagan, T R M, Najumudeen, A K, Gilroy, K L, Amirkhah, R, Maguire, S L, Mulholland, E J, Belnoue-Davis, H L, Grassi, E, Viviani, M, Rogan, E, Redmond, K L, Sakhnevych, S, McCooey, A J, Bull, C, Hoey, E, Sinevici, N, Hall, H, Ahmaderaghi, B, Domingo, E, Blake, A, Richman, S D, Isella, C, Miller, C, Bertotti, A, Trusolino, L, Loughrey, M B, Kerr, E M, Tejpar, S, Maughan, T S, Lawler, M, Campbell, A D, Leedham, S J, Koelzer, V H, Sansom, O J, Dunne, P D & S:CORT consortium 2024, 'Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer', Nature Genetics, vol. 56, no. 3, pp. 458-472. https://doi.org/10.1038/s41588-024-01654-5